Docencia

Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study

Dr. Enrique Bernal. Unidad de Enfermedades Infecciosas. Hospital General Universitario Reina Sofía

Mechanisms that contribute to a profound reduction of the HIV-1 reservoir after allogeneic stem cell transplant

Dra. Luz Martín Carbonero. Medicina Interna. Hospital Universitario La Paz, Madrid

Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/Hepatitis C virus-coinfected patients

Dr. Juan Luis Gómez Sirvent. Sección de infecciones. Hospital Universitario de Canarias, Santa Cruz de Tenerife

Birth outcomes for pregnant women with HIV using Tenofovir-Emtricitabine

Dra. Carmen Hidalgo. FEA de la Unidad de Gestión Clínica de Enfermedades Infecciosas. Hospital Universitario Virgen de las Nieves, Granada

A randomized clinical trial of infrared coagulation ablation versus active monitoring of intra-anal high-grade dysplasia in adults with human immunodeficiency virus infection: an aids malignancy consortium trial

Dra. María Saumoy. Unidad de VIH y ETS. Servicio de Enfermedades Infecciosas. Hospital Universitario de Bellvitge, Barcelona

Benefits and harms of lung cancer screening in HIV-infected individuals with CD4+ cell count at least 500 cells/ml

Dr.Pablo Ryan. Servicio de Medicina Interna. Hospital Universitario Infanta Leonor. Madrid

Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study

Dr. Enrique Bernal. Unidad de Enfermedades Infecciosas. Hospital General Universitario Reina Sofía.

Phase 3 study of Ibalizumab for multidrug-resistant HIV-1

Dra. Luz Martín Carbonero. Medicina Interna. Hospital Universitario La Paz, Madrid.

Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults HIV-1 (DRIVE-FORWARD): 48- week results of a randomised, double-blind, phase 3, non inferiority trial

Dr. Julián Olalla Sierra. Especialista en Medicina Interna Hospital Costa del Sol, Marbella

Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial

Dra. Marta Montero Alonso. Unidad de Enfermedades Infecciosas. Hospital Universitario y Politécnico la Fe, Valencia.

Recent Abacavir Use Increases Risk of Type 1 and Type 2 Myocardial Infarctions Among Adults With HIV

Dra. Matilde Sánchez Conde. Infectious Diseases Unit. Hospital Ramón y Cajal, Madrid

Tenofovir alafenamide plus emtricitabine versus abacavir plus lamivudine for treatment of virologically suppressed HIV-1-infected adults: a randomised, double-blind, active-controlled, non-inferiority phase 3 trial

Dr. Arkaitz Imaz. Servicio de Enfermedades Infecciosas Hospital Universitario de Bellvitge, Barcelona

Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial

Dr. Esteban Martínez. Infectious Diseases Unit. Hospital Clínic, University of Barcelona

Disparities in the Quality of Cardiovascular Care Between HIV-Infected Versus HIVUninfected Adults in the United States: A Cross-Sectional Study

Dra. Ana Mariño. Unidad de VIH. Hospital Arquitecto Marcide-Novoa Santos, A Coruña.

Non Antiretrocial Polypharmacy and Adverse Health Outcomes Amon HIV. Infected and Uninfected Individuals

Dr. Julián Olalla Sierra. Especialista en Medicina Interna Hospital Costa del Sol, Marbella

Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial

Dra. Marta Montero Alonso. Unidad de Enfermedades Infecciosas. Hospital Universitario y Politécnico la Fe, Valencia.

Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies

Dra. Matilde Sánchez Conde. Infectious Diseases Unit. Hospital Ramón y Cajal, Madrid

Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance ofHIV viral suppression in patients with high cardiovascular

Dr. Esteban Martínez. Infectious Diseases Unit. Hospital Clínic, University of Barcelona

HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review andmeta-regression analysis

Dr. Arkaitz Imaz. Servicio de Enfermedades Infecciosas Hospital Universitario de Bellvitge, Barcelona

Página 2 de 512345

Accesos directos